CJC-1295 (No DAC) / Ipamorelin – Research Peptide Blend 5/5mg

CJC-1295 (No DAC) / Ipamorelin is a laboratory research peptide blend that combines two investigational compounds studied for their complementary actions on the growth hormone regulatory axis. CJC-1295 (No DAC), also known as Modified GRF (1-29), is a short-acting analog of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue that targets the ghrelin (GHS-R1a) receptor. Researchers frequently study these peptides together to investigate how dual-pathway activation influences endogenous growth hormone signaling.

Unlike the long-acting CJC-1295 formulation containing a Drug Affinity Complex (DAC), CJC-1295 (No DAC) was designed without the albumin-binding modification, resulting in a substantially shorter duration of activity. This distinction has made the No DAC form a valuable research tool for studying pulsatile growth hormone physiology and receptor signaling under laboratory conditions.